vialauditThe Roundup

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

vendor audit · public-data tier

Is Hello Stacks legit?

Hello Stacks is operating and surfaces credible public signals (composite 66/100), but we have not placed a first-hand test order yet — this is a public-data audit. All 31 published Vanguard reports resolve and fills median 107.3% of label, but no vial report tests identity and the shop sells HGH. Public-data audit. The signal table below shows what we verified and what is still open.

PREVIEW · NO TEST ORDER YET66/100 composite
Synthesized from public signals — first-hand audit pending. Last reviewed 2026-10-09.

Signal table

Status
Active
Audit tier
public-data only
Composite score
66/100· PREVIEW — synthesized from public signals, first-hand audit pending
Ships to
US
Payment
card, ach
Last reviewed
2026-10-09

What works, what does not

pros
  • +All 31 Vanguard Laboratory reports the shop lists resolve on the lab's public portal under client "Hello Stacks" (checked 9 October 2026), once the broken MOTS-c 10 mg link is corrected
  • +Fill runs generous rather than short - median 107.3% of label across the 31 listed reports, range 92.5-125.0%, none under 90%
  • +All 19 Freedom Diagnostics reports for the StackOne pen line resolve, and those include an LC-MS identity line
  • +Vials price well under our index on several compounds - BPC-157 and TB-500 about 42% below the median per mg, NAD+ 64-73% below (index built 25 June 2026)
  • +Shipping terms are published with a cutoff (2:00 PM PST same-day dispatch) and named carriers
cons
  • −None of the 34 Vanguard vial records includes an identity test, although the shop's own buyer checklist asks for "Mass spec identity confirmation"
  • −Lot codes are shared across up to nine different compounds, so they cannot identify a production batch
  • −The shop sells HGH (somatropin) 10 IU and 24 IU vials; somatropin is an FDA-approved prescription drug with its own distribution restriction in federal law
  • −GLP code-name vials, bac water, a reconstitution calculator, prefilled pens and 4-weekly refill plans match the practices FDA cited in its 2026 warning letters
  • −The listed address is a Regus virtual office in Costa Mesa; no officer of the operator, PranaCore Life Inc., is named anywhere we looked
  • −StackOne pens cost a median 3.05x the per-mg price of the same compound in a Hello Stacks vial
  • −No customer reports found - two Reddit posts from 10 April 2026, one removed by moderators, are the whole public footprint

What we mean by "legit"

We do not use "legit" as a single yes-or-no signal. A vendor is legit when four things hold: identifiable corporate operator, third-party or independently-mirrored COAs, shipping and payment infrastructure that consistently delivers, and a complaint history that surfaces real issues rather than vanishes them. Our composite score is the weighted average of those four — shipping, pricing, support, COA quality — and you can read the full rubric at /methodology.

For Hello Stacks the audit is "public-data tier" — we aggregate vendor disclosures, third-party COA mirrors, operating-history evidence, and complaint patterns. A first-hand test order is still pending and the page will be upgraded when that lands.

one-line verdict

All 31 published Vanguard reports resolve and fills median 107.3% of label, but no vial report tests identity and the shop sells HGH. Public-data audit.

composite 66/100 · audit tier public-data · last reviewed 2026-10-09

Other audited vendors

is ascension-peptides legit?
Ascension Peptides
84/100 · public-data
is biotech-peptides legit?
BioTech Peptides
76/100 · public-data
is certapeptides legit?
CertaPeptides
78/100 · public-data

Sources

THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH